title: F-18 FDG uptake in endometrial cancer.
abstract: Endometrial cancer, which is one of the most common malignant gynecologic diseases, was detected by F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) in a 60-year-old woman with abdominal distention. FDG PET revealed heterogeneous and marked accumulation in the endometrium, which was thought to represent endometrial cancer. In addition, focal intense accumulation of FDG in both lungs suggestive of lung metastases were noted. Endometrial cancer and lung metastases were confirmed by endometrial biopsy and computed tomography of the chest, respectively.
authors.affiliation: HIMEDIC Imaging Center at Lake Yamanaka, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Nakahara
authors.forename: H
authors.initials: H
authors.lastname: Fujii
authors.forename: M
authors.initials: M
authors.lastname: Ide
authors.forename: Y
authors.initials: Y
authors.lastname: Mochizuki
authors.forename: W
authors.initials: W
authors.lastname: Takahashi
authors.forename: S
authors.initials: S
authors.lastname: Yasuda
authors.forename: A
authors.initials: A
authors.lastname: Shohtsu
authors.forename: A
authors.initials: A
authors.lastname: Kubo
mesh_terms: D016889:Endometrial Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D004717:Endometrium / Q000000981:diagnostic imaging; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary; D008875:Middle Aged; D019275:Radiopharmaceuticals; D014055:Tomography, Emission-Computed
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18